Follow the 신라젠 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 신라젠 has logged 33 insider filings. The latest transaction was disclosed on 2 July 2025 (Purchase). Among the most active insiders: 엠투엔. Every trade is accessible without an account.
33
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.